Advertisement

Index by author

January 01, 1984; Volume 228,Issue 1

A

  1. Agnes, M

    1. Effects of prostaglandin E1 on canine nasal vascular and airway resistances.
      M Agnes, K Y Lung and J C Wang
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 215-219;

  2. Aguayo, L G

    1. Discriminant effects of behaviorally active and inactive analogs of phencyclidine on membrane electrical excitability.
      L G Aguayo, H Weinstein, S Maayani, S D Glick, J E Warnick and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 80-87;

  3. Ahmed, K

    1. Effects of methanethiol on erythrocyte membrane stabilization and on Na+,K+-adenosine triphosphatase: relevance to hepatic coma.
      K Ahmed, L Zieve and G Quarfoth
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 103-108;

  4. Akaike, N

    1. Permeability to various cations of the voltage-dependent sodium channel of rat single heart cells.
      N Akaike, A Yatani, K Nishi, Y Oyama and S Kuraoka
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 225-229;

  5. Albuquerque, E X

    1. Interaction of bicyclo-octane analogs of amantadine with ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
      J E Warnick, M A Maleque and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 73-79;
    2. Discriminant effects of behaviorally active and inactive analogs of phencyclidine on membrane electrical excitability.
      L G Aguayo, H Weinstein, S Maayani, S D Glick, J E Warnick and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 80-87;

  6. Alderdice, M T

    1. Effects of primidone, phenobarbital and phenylethylmalonamide in the stimulated frog neuromuscular junction.
      P A Talbot and M T Alderdice
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 121-127;

  7. Andersson, K E

    1. Mechanisms behind the biphasic contractile response to potassium depolarization in isolated rat cerebral arteries.
      E D Högestätt and K E Andersson
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 187-195;

B

  1. Bartsch, W

    1. Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.
      G Sponer, H F Kühnle, K Strein, W Bartsch, R Endele and K Dietmann
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 235-239;

  2. Baruth, H

    1. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
      A F Welton, W C Hope, M O'Donnell, H Baruth, H J Crowley, D A Miller and B Yaremko
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 57-64;

  3. Berry, P N

    1. Role of microsomal and cytosolic glutathione S-transferases in the conjugation of hexachloro-1:3-butadiene and its possible relevance to toxicity.
      C R Wolf, P N Berry, J A Nash, T Green and E A Lock
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 202-208;

  4. Brocco, M J

    1. Reinstatement of responding maintained by cocaine or thiamylal.
      W Slikker, M J Brocco and K F Killam
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 43-52;

C

  1. Cieslinski, L

    1. Mechanisms involved in the hyperglycemic response induced by clonidine and other alpha-2 adrenoceptor agonists.
      N W DiTullio, L Cieslinski, W D Matthews and B Storer
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 168-173;

  2. Cone, E J

    1. Structure-activity relationship studies of phencyclidine derivatives in rats.
      E J Cone, R L McQuinn and H E Shannon
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 147-153;

  3. Crowley, H J

    1. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
      A F Welton, W C Hope, M O'Donnell, H Baruth, H J Crowley, D A Miller and B Yaremko
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 57-64;

D

  1. de Montigny, C

    1. Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin.
      C de Montigny
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 230-234;

  2. Dietmann, K

    1. Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.
      G Sponer, H F Kühnle, K Strein, W Bartsch, R Endele and K Dietmann
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 235-239;

  3. DiTullio, N W

    1. Mechanisms involved in the hyperglycemic response induced by clonidine and other alpha-2 adrenoceptor agonists.
      N W DiTullio, L Cieslinski, W D Matthews and B Storer
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 168-173;

  4. Dresel, P E

    1. Effect of encainide and its two major metabolites on cardiac conduction.
      P E Dresel
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 180-186;

E

  1. Edwards, J C

    1. Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP.
      J C Edwards, L J Ignarro, A L Hyman and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 33-42;

  2. Endele, R

    1. Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.
      G Sponer, H F Kühnle, K Strein, W Bartsch, R Endele and K Dietmann
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 235-239;

F

  1. Feigen, L P

    1. Influence of renal lipoxygenase activity on the renal vascular response to arachidonic acid.
      L P Feigen
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 140-146;

  2. Fischli, W

    1. Opioid receptor selectivity of dynorphin gene products.
      I F James, W Fischli and A Goldstein
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 88-93;

  3. Fowler, P J

    1. Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice.
      L M Yunger, P J Fowler, P Zarevics and P E Setler
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 109-115;

  4. Frazer, A

    1. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
      I Lucki, M S Nobler and A Frazer
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 133-139;

  5. Fuhrman-Lane, C

    1. Morphine-morphine glucuronide pools in the rat liver: effects of Triton X-100.
      E F Sweeney, C Fuhrman-Lane and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 19-27;

  6. Fujimoto, J M

    1. Morphine-morphine glucuronide pools in the rat liver: effects of Triton X-100.
      E F Sweeney, C Fuhrman-Lane and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 19-27;

G

  1. Gillis, C N

    1. Analysis of rabbit pulmonary angiotensin converting enzyme kinetics in vivo.
      R E Howell, R Moalli and C N Gillis
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 154-160;

  2. Gleason, J G

    1. SK&F 88046: a unique pharmacologic antagonist of bronchoconstriction induced by leukotriene D4, thromboxane and prostaglandins F2 alpha and D2 in vitro.
      B M Weichman, M A Wasserman and J G Gleason
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 128-132;

  3. Glick, S D

    1. Discriminant effects of behaviorally active and inactive analogs of phencyclidine on membrane electrical excitability.
      L G Aguayo, H Weinstein, S Maayani, S D Glick, J E Warnick and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 80-87;

  4. Goldstein, A

    1. Opioid receptor selectivity of dynorphin gene products.
      I F James, W Fischli and A Goldstein
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 88-93;

  5. Green, T

    1. Role of microsomal and cytosolic glutathione S-transferases in the conjugation of hexachloro-1:3-butadiene and its possible relevance to toxicity.
      C R Wolf, P N Berry, J A Nash, T Green and E A Lock
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 202-208;

  6. Gross, G J

    1. Differential effects of intravenous vs. intracoronary nifedipine on myocardial segment function in ischemic canine hearts.
      K A Lamping and G J Gross
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 28-32;

H

  1. Hall, S

    1. Relationship between renal clearance, protein binding and urine flow for digitoxin, a compound of low clearance in the isolated perfused rat kidney.
      S Hall and M Rowland
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 174-179;

  2. Hedner, J

    1. Interaction of substance P with the respiratory control system in the rat.
      J Hedner, T Hedner, P Wessberg and J Jonason
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 196-201;

  3. Hedner, T

    1. Interaction of substance P with the respiratory control system in the rat.
      J Hedner, T Hedner, P Wessberg and J Jonason
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 196-201;

  4. Högestätt, E D

    1. Mechanisms behind the biphasic contractile response to potassium depolarization in isolated rat cerebral arteries.
      E D Högestätt and K E Andersson
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 187-195;

  5. Hope, W C

    1. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
      A F Welton, W C Hope, M O'Donnell, H Baruth, H J Crowley, D A Miller and B Yaremko
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 57-64;

  6. Howell, R E

    1. Analysis of rabbit pulmonary angiotensin converting enzyme kinetics in vivo.
      R E Howell, R Moalli and C N Gillis
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 154-160;

  7. Hyman, A L

    1. Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP.
      J C Edwards, L J Ignarro, A L Hyman and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 33-42;

I

  1. Ignarro, L J

    1. Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP.
      J C Edwards, L J Ignarro, A L Hyman and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 33-42;

  2. Itskovitz, H D

    1. Serotonin formation in nonblood-perfused rat kidneys.
      C T Stier, G McKendall and H D Itskovitz
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 53-56;

J

  1. James, I F

    1. Opioid receptor selectivity of dynorphin gene products.
      I F James, W Fischli and A Goldstein
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 88-93;

  2. Jonason, J

    1. Interaction of substance P with the respiratory control system in the rat.
      J Hedner, T Hedner, P Wessberg and J Jonason
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 196-201;

K

  1. Kadowitz, P J

    1. Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP.
      J C Edwards, L J Ignarro, A L Hyman and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 33-42;

  2. Kaloyanides, G J

    1. Renal transport of netilmicin in the rat.
      E Pastoriza-Munoz, D Timmerman and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 65-72;

  3. Kanaide, H

    1. Effects of diltiazem on the calcium paradox in isolated rat hearts.
      H Meno, H Kanaide and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 220-224;

  4. Kanaya, S

    1. Effects of diltiazem on transmembrane potential and current of right ventricular papillary muscle of ferrets.
      S Kanaya and B G Katzung
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 245-251;

  5. Katzung, B G

    1. Effects of diltiazem on transmembrane potential and current of right ventricular papillary muscle of ferrets.
      S Kanaya and B G Katzung
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 245-251;

  6. Killam, K F

    1. Reinstatement of responding maintained by cocaine or thiamylal.
      W Slikker, M J Brocco and K F Killam
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 43-52;

  7. Kühnle, H F

    1. Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.
      G Sponer, H F Kühnle, K Strein, W Bartsch, R Endele and K Dietmann
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 235-239;

  8. Kuraoka, S

    1. Permeability to various cations of the voltage-dependent sodium channel of rat single heart cells.
      N Akaike, A Yatani, K Nishi, Y Oyama and S Kuraoka
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 225-229;

L

  1. Lamping, K A

    1. Differential effects of intravenous vs. intracoronary nifedipine on myocardial segment function in ischemic canine hearts.
      K A Lamping and G J Gross
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 28-32;

  2. Lazo, J S

    1. Pulmonary fate of [3H]bleomycin A2 in mice.
      J S Lazo and E T Pham
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 13-18;

  3. Leardi, R

    1. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain.
      M Raiteri, R Leardi and M Marchi
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 209-214;

  4. Le Breton, G C

    1. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
      L V Parise, D L Venton and G C Le Breton
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 240-244;

  5. Lock, E A

    1. Role of microsomal and cytosolic glutathione S-transferases in the conjugation of hexachloro-1:3-butadiene and its possible relevance to toxicity.
      C R Wolf, P N Berry, J A Nash, T Green and E A Lock
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 202-208;

  6. Lokhandwala, M F

    1. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine.
      M F Lokhandwala and M L Steenberg
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 161-167;

  7. Lucki, I

    1. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
      I Lucki, M S Nobler and A Frazer
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 133-139;

  8. Lung, K Y

    1. Effects of prostaglandin E1 on canine nasal vascular and airway resistances.
      M Agnes, K Y Lung and J C Wang
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 215-219;

M

  1. Maayani, S

    1. Discriminant effects of behaviorally active and inactive analogs of phencyclidine on membrane electrical excitability.
      L G Aguayo, H Weinstein, S Maayani, S D Glick, J E Warnick and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 80-87;

  2. Maleque, M A

    1. Interaction of bicyclo-octane analogs of amantadine with ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
      J E Warnick, M A Maleque and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 73-79;

  3. Marchi, M

    1. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain.
      M Raiteri, R Leardi and M Marchi
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 209-214;

  4. Matthews, W D

    1. Mechanisms involved in the hyperglycemic response induced by clonidine and other alpha-2 adrenoceptor agonists.
      N W DiTullio, L Cieslinski, W D Matthews and B Storer
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 168-173;

  5. McKendall, G

    1. Serotonin formation in nonblood-perfused rat kidneys.
      C T Stier, G McKendall and H D Itskovitz
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 53-56;

  6. McQuinn, R L

    1. Structure-activity relationship studies of phencyclidine derivatives in rats.
      E J Cone, R L McQuinn and H E Shannon
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 147-153;

  7. Meno, H

    1. Effects of diltiazem on the calcium paradox in isolated rat hearts.
      H Meno, H Kanaide and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 220-224;

  8. Miller, D A

    1. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
      A F Welton, W C Hope, M O'Donnell, H Baruth, H J Crowley, D A Miller and B Yaremko
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 57-64;

  9. Moalli, R

    1. Analysis of rabbit pulmonary angiotensin converting enzyme kinetics in vivo.
      R E Howell, R Moalli and C N Gillis
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 154-160;

N

  1. Nakamura, M

    1. Effects of diltiazem on the calcium paradox in isolated rat hearts.
      H Meno, H Kanaide and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 220-224;

  2. Nash, J A

    1. Role of microsomal and cytosolic glutathione S-transferases in the conjugation of hexachloro-1:3-butadiene and its possible relevance to toxicity.
      C R Wolf, P N Berry, J A Nash, T Green and E A Lock
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 202-208;

  3. Nishi, K

    1. Permeability to various cations of the voltage-dependent sodium channel of rat single heart cells.
      N Akaike, A Yatani, K Nishi, Y Oyama and S Kuraoka
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 225-229;

  4. Nobler, M S

    1. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
      I Lucki, M S Nobler and A Frazer
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 133-139;

O

  1. O'Donnell, M

    1. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
      A F Welton, W C Hope, M O'Donnell, H Baruth, H J Crowley, D A Miller and B Yaremko
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 57-64;

  2. Oyama, Y

    1. Permeability to various cations of the voltage-dependent sodium channel of rat single heart cells.
      N Akaike, A Yatani, K Nishi, Y Oyama and S Kuraoka
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 225-229;

P

  1. Parise, L V

    1. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
      L V Parise, D L Venton and G C Le Breton
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 240-244;

  2. Pastoriza-Munoz, E

    1. Renal transport of netilmicin in the rat.
      E Pastoriza-Munoz, D Timmerman and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 65-72;

  3. Perez-Gonzalez, M

    1. Effects of p-aminohippurate and pyrazinoate on urate excretion in Cebus monkeys.
      M Perez-Gonzalez and I M Weiner
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 252-255;

  4. Pham, E T

    1. Pulmonary fate of [3H]bleomycin A2 in mice.
      J S Lazo and E T Pham
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 13-18;

  5. Preussler, D W

    1. Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.
      M E Trulson, D W Preussler and V M Trulson
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 94-102;

Q

  1. Quarfoth, G

    1. Effects of methanethiol on erythrocyte membrane stabilization and on Na+,K+-adenosine triphosphatase: relevance to hepatic coma.
      K Ahmed, L Zieve and G Quarfoth
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 103-108;

R

  1. Raiteri, M

    1. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain.
      M Raiteri, R Leardi and M Marchi
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 209-214;

  2. Regal, J F

    1. Immunoglobulin G- and immunoglobulin E-mediated airway smooth muscle contraction in the guinea pig.
      J F Regal
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 116-120;

  3. Rowland, M

    1. Relationship between renal clearance, protein binding and urine flow for digitoxin, a compound of low clearance in the isolated perfused rat kidney.
      S Hall and M Rowland
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 174-179;

S

  1. Schmauss, C

    1. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
      C Schmauss and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 1-12;

  2. Setler, P E

    1. Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice.
      L M Yunger, P J Fowler, P Zarevics and P E Setler
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 109-115;

  3. Shannon, H E

    1. Structure-activity relationship studies of phencyclidine derivatives in rats.
      E J Cone, R L McQuinn and H E Shannon
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 147-153;

  4. Slikker, W

    1. Reinstatement of responding maintained by cocaine or thiamylal.
      W Slikker, M J Brocco and K F Killam
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 43-52;

  5. Sponer, G

    1. Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.
      G Sponer, H F Kühnle, K Strein, W Bartsch, R Endele and K Dietmann
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 235-239;

  6. Steenberg, M L

    1. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine.
      M F Lokhandwala and M L Steenberg
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 161-167;

  7. Stier, C T

    1. Serotonin formation in nonblood-perfused rat kidneys.
      C T Stier, G McKendall and H D Itskovitz
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 53-56;

  8. Storer, B

    1. Mechanisms involved in the hyperglycemic response induced by clonidine and other alpha-2 adrenoceptor agonists.
      N W DiTullio, L Cieslinski, W D Matthews and B Storer
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 168-173;

  9. Strein, K

    1. Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.
      G Sponer, H F Kühnle, K Strein, W Bartsch, R Endele and K Dietmann
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 235-239;

  10. Sweeney, E F

    1. Morphine-morphine glucuronide pools in the rat liver: effects of Triton X-100.
      E F Sweeney, C Fuhrman-Lane and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 19-27;

T

  1. Talbot, P A

    1. Effects of primidone, phenobarbital and phenylethylmalonamide in the stimulated frog neuromuscular junction.
      P A Talbot and M T Alderdice
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 121-127;

  2. Timmerman, D

    1. Renal transport of netilmicin in the rat.
      E Pastoriza-Munoz, D Timmerman and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 65-72;

  3. Trulson, M E

    1. Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.
      M E Trulson, D W Preussler and V M Trulson
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 94-102;

  4. Trulson, V M

    1. Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.
      M E Trulson, D W Preussler and V M Trulson
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 94-102;

V

  1. Venton, D L

    1. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
      L V Parise, D L Venton and G C Le Breton
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 240-244;

W

  1. Wang, J C

    1. Effects of prostaglandin E1 on canine nasal vascular and airway resistances.
      M Agnes, K Y Lung and J C Wang
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 215-219;

  2. Warnick, J E

    1. Interaction of bicyclo-octane analogs of amantadine with ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
      J E Warnick, M A Maleque and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 73-79;
    2. Discriminant effects of behaviorally active and inactive analogs of phencyclidine on membrane electrical excitability.
      L G Aguayo, H Weinstein, S Maayani, S D Glick, J E Warnick and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 80-87;

  3. Wasserman, M A

    1. SK&F 88046: a unique pharmacologic antagonist of bronchoconstriction induced by leukotriene D4, thromboxane and prostaglandins F2 alpha and D2 in vitro.
      B M Weichman, M A Wasserman and J G Gleason
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 128-132;

  4. Weichman, B M

    1. SK&F 88046: a unique pharmacologic antagonist of bronchoconstriction induced by leukotriene D4, thromboxane and prostaglandins F2 alpha and D2 in vitro.
      B M Weichman, M A Wasserman and J G Gleason
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 128-132;

  5. Weiner, I M

    1. Effects of p-aminohippurate and pyrazinoate on urate excretion in Cebus monkeys.
      M Perez-Gonzalez and I M Weiner
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 252-255;

  6. Weinstein, H

    1. Discriminant effects of behaviorally active and inactive analogs of phencyclidine on membrane electrical excitability.
      L G Aguayo, H Weinstein, S Maayani, S D Glick, J E Warnick and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 80-87;

  7. Welton, A F

    1. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
      A F Welton, W C Hope, M O'Donnell, H Baruth, H J Crowley, D A Miller and B Yaremko
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 57-64;

  8. Wessberg, P

    1. Interaction of substance P with the respiratory control system in the rat.
      J Hedner, T Hedner, P Wessberg and J Jonason
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 196-201;

  9. Wolf, C R

    1. Role of microsomal and cytosolic glutathione S-transferases in the conjugation of hexachloro-1:3-butadiene and its possible relevance to toxicity.
      C R Wolf, P N Berry, J A Nash, T Green and E A Lock
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 202-208;

Y

  1. Yaksh, T L

    1. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
      C Schmauss and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 1-12;

  2. Yaremko, B

    1. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
      A F Welton, W C Hope, M O'Donnell, H Baruth, H J Crowley, D A Miller and B Yaremko
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 57-64;

  3. Yatani, A

    1. Permeability to various cations of the voltage-dependent sodium channel of rat single heart cells.
      N Akaike, A Yatani, K Nishi, Y Oyama and S Kuraoka
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 225-229;

  4. Yunger, L M

    1. Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice.
      L M Yunger, P J Fowler, P Zarevics and P E Setler
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 109-115;

Z

  1. Zarevics, P

    1. Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice.
      L M Yunger, P J Fowler, P Zarevics and P E Setler
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 109-115;

  2. Zieve, L

    1. Effects of methanethiol on erythrocyte membrane stabilization and on Na+,K+-adenosine triphosphatase: relevance to hepatic coma.
      K Ahmed, L Zieve and G Quarfoth
      Journal of Pharmacology and Experimental Therapeutics January 1984, 228 (1) 103-108;
Back to top

In this issue

Advertisement